The INI1/SMARCB1/hSNF5 gene on chromosome 22 is frequently mutated in rhabd
oid tumors. An association of INI1 mutations with allelic losses on chromos
ome 22 supports a classical tumor suppressor mechanism. Several brain tumor
entities including astrocytomas, glioblastomas and ependymomas are charact
erized by allelic losses on chromosome 22. In the present study we examined
a series of 200 brain turners by Single-strand conformation polymorphism a
nalysis and direct sequencing for paint mutations in INI1. In addition, all
tumors were analyzed for homozygous deletions spanning both exons 3 and 8
of INI1. No mutations or homozygous deletions were detected in astrocytomas
, glioblastomas, oligodendroglial tumors, neurinomas or medulloblastomas. H
owever, a point mutation could be identified in the single case of plexus c
arcinoma. Our data suggest that INI1 mutations are involved in the pathogen
esis of plexus carcinoma; however, INI1 alterations are not a frequent even
t in the majority of brain tumor entities.